aurora cannabis

Canadian marijuana firm Aurora’s sales surge, losses widen

Aurora Cannabis, an Edmonton, Alberta-based cannabis producer, reported fiscal third-quarter revenue of 75 million Canadian dollars ($56 million) – up more than 365% from a year ago. The company’s net loss grew to CA$158.3 million – up from $19.2 million in the year-ago quarter. The boost in sales was fueled by growth across its key markets, […]

Read More

Danish medical cannabis market sees significant growth in first year

The number of patients who received medical cannabis prescriptions in Denmark more than tripled in the initial year of the country’s program, exceeding expectations of executives in the country. However, more needs to be done to lower prices, expand product selection and further improve access, the executives said. Prescriptions of medical cannabis products in Denmark […]

Read More

Aurora Cannabis exec: ‘Having a major presence in US is nonnegotiable’

Aurora Cannabis is vowing to not be a spectator as rival Canopy Growth continues to plow hundreds of millions of dollars into high-growth U.S. CBD and medical marijuana markets. Aurora CCO Cam Battley told Jefferies analyst Owen Bennett that the Alberta company is closely watching developments in the United States. “Having a major presence in […]

Read More

Sale of locally grown cannabis, exports in Denmark expected as soon as summer

Five companies in Denmark have applied for licenses to sell and export medical cannabis so far, putting the country on track to see its first cross-border shipment to key European Union markets as early as late summer. Authorization to sell medical cannabis products cultivated and produced in Denmark is going to be key to lowering […]

Read More

Merrill Lynch launches marijuana sector coverage, predicts more cross-border deals

Bank of America Merrill Lynch deepened its interest in the cannabis industry by initiating coverage of the burgeoning sector, less than a year after it financed Constellation’s multibillion-dollar investment in Canada’s Canopy Growth. The report, by analyst Chris Carey, predicts two events may lead to a paradigm shift: Canada reaching marijuana oversupply by 2021. U.S. legalization. “Importantly, whether […]

Read More

Swedish state-owned pension fund invests in Aurora Cannabis, Canopy

A Swedish state-owned pension fund has invested in cannabis companies for the first time. More government-run pension funds are dipping into large-cap cannabis stocks, a sign that such investments are going more mainstream. Canada’s Public Sector Pension Investment Board recently boosted its stake in Ontario’s Canopy Growth and took positions in three more multinational Canadian […]

Read More

Capital-hungry Aurora Cannabis looks to raise CA$1 billion

Aurora Cannabis laid the foundation to raise up to $750 million (1 billion Canadian dollars) to fuel potential future acquisitions, other capital expenditures and debt repayments. The Edmonton, Alberta-based company filed a base shelf prospectus with Canadian securities agencies and a corresponding shelf registration statement with the U.S. Securities and Exchange Commission. The filing would clear the […]

Read More

Tilray expects GMP approval, first cannabis sales from Portugal this summer

Tilray’s facility in Portugal is expected to receive Good Manufacturing Practice (GMP) certification in the coming months, which the Canada-based cannabis company says will open the door for the first shipments from its European facility as early as this summer. Monetizing European demand for medical cannabis is core to the strategies of many publicly traded cannabis […]

Read More